A phase II prospective, multi-institutional trial (CALGB 89903) of adjuvant active specific immunotherapy following curative resection of colorectal cancer(CRC) hepatic metastases
Publication
, Conference
Posner, MC; Niedzwiecki, D; Venook, AP; Hollis, DR; Schilsky, RL; Goldberg, RM; Mayer, RJ
Published in: ANNALS OF SURGICAL ONCOLOGY
February 1, 2007
Duke Scholars
Published In
ANNALS OF SURGICAL ONCOLOGY
ISSN
1068-9265
Publication Date
February 1, 2007
Volume
14
Issue
2
Start / End Page
3 / 3
Location
Washington, DC
Publisher
SPRINGER
Conference Name
60th Annual Cancer Symposium of the Society-of-Surgical-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Posner, M. C., Niedzwiecki, D., Venook, A. P., Hollis, D. R., Schilsky, R. L., Goldberg, R. M., & Mayer, R. J. (2007). A phase II prospective, multi-institutional trial (CALGB 89903) of adjuvant active specific immunotherapy following curative resection of colorectal cancer(CRC) hepatic metastases. In ANNALS OF SURGICAL ONCOLOGY (Vol. 14, pp. 3–3). Washington, DC: SPRINGER.
Posner, M. C., D. Niedzwiecki, A. P. Venook, D. R. Hollis, R. L. Schilsky, R. M. Goldberg, and R. J. Mayer. “A phase II prospective, multi-institutional trial (CALGB 89903) of adjuvant active specific immunotherapy following curative resection of colorectal cancer(CRC) hepatic metastases.” In ANNALS OF SURGICAL ONCOLOGY, 14:3–3. SPRINGER, 2007.
Posner MC, Niedzwiecki D, Venook AP, Hollis DR, Schilsky RL, Goldberg RM, et al. A phase II prospective, multi-institutional trial (CALGB 89903) of adjuvant active specific immunotherapy following curative resection of colorectal cancer(CRC) hepatic metastases. In: ANNALS OF SURGICAL ONCOLOGY. SPRINGER; 2007. p. 3–3.
Posner, M. C., et al. “A phase II prospective, multi-institutional trial (CALGB 89903) of adjuvant active specific immunotherapy following curative resection of colorectal cancer(CRC) hepatic metastases.” ANNALS OF SURGICAL ONCOLOGY, vol. 14, no. 2, SPRINGER, 2007, pp. 3–3.
Posner MC, Niedzwiecki D, Venook AP, Hollis DR, Schilsky RL, Goldberg RM, Mayer RJ. A phase II prospective, multi-institutional trial (CALGB 89903) of adjuvant active specific immunotherapy following curative resection of colorectal cancer(CRC) hepatic metastases. ANNALS OF SURGICAL ONCOLOGY. SPRINGER; 2007. p. 3–3.
Published In
ANNALS OF SURGICAL ONCOLOGY
ISSN
1068-9265
Publication Date
February 1, 2007
Volume
14
Issue
2
Start / End Page
3 / 3
Location
Washington, DC
Publisher
SPRINGER
Conference Name
60th Annual Cancer Symposium of the Society-of-Surgical-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis